MedPath
FDA Approval

Dilantin Infatabs

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
Parke-Davis Div of Pfizer Inc
DUNS: 829076962
Effective Date
September 27, 2023
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Phenytoin(50 mg in 1 1)

Registrants1

Companies and organizations registered with the FDA for this drug approval, including their contact information and regulatory details.

Pfizer Inc

113480771

Manufacturing Establishments1

FDA-registered manufacturing facilities and establishments involved in the production, packaging, or distribution of this drug product.

Pharmacia & Upjohn Company LLC

Parke-Davis Div of Pfizer Inc

Pfizer Inc

618054084

Products1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Dilantin Infatabs

Product Details

NDC Product Code
0071-0007
Application Number
ANDA084427
Marketing Category
ANDA (C73584)
Route of Administration
ORAL
Effective Date
March 21, 2022
SUCROSEInactive
Code: C151H8M554Class: IACT
PhenytoinActive
Code: 6158TKW0C5Class: ACTIBQuantity: 50 mg in 1 1
D&C YELLOW NO. 10 ALUMINUM LAKEInactive
Code: CQ3XH3DET6Class: IACT
FD&C YELLOW NO. 6Inactive
Code: H77VEI93A8Class: IACT
SACCHARIN SODIUMInactive
Code: SB8ZUX40TYClass: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30Class: IACT
TALCInactive
Code: 7SEV7J4R1UClass: IACT
WATERInactive
Code: 059QF0KO0RClass: IACT
© Copyright 2025. All Rights Reserved by MedPath